{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:03:04Z","timestamp":1762866184792},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,5,17]],"date-time":"2013-05-17T00:00:00Z","timestamp":1368748800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s40261-013-0086-9","type":"journal-article","created":{"date-parts":[[2013,5,16]],"date-time":"2013-05-16T07:51:59Z","timestamp":1368690719000},"page":"469-476","source":"Crossref","is-referenced-by-count":17,"title":["Twenty-Four-Hour Ambulatory Blood Pressure Reduction with a Perindopril\/Amlodipine Fixed-Dose Combination"],"prefix":"10.1007","volume":"33","author":[{"given":"Viktor L.","family":"Nagy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,17]]},"reference":[{"key":"86_CR1","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/bmj.d4891","volume":"343","author":"T Krause","year":"2011","unstructured":"Krause T, Lovibond K, Caulfield M, et al. Management of hypertension: summary of NICE guidance. BMJ. 2011;343:474\u20138.","journal-title":"BMJ"},{"key":"86_CR2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00004872-199204000-00011","volume":"10","author":"AJ Coats","year":"1992","unstructured":"Coats AJ, Radaelli A, Clark SJ, et al. The influence of ambulatory blood pressure monitoring on the design and interpretation of trials in hypertension. J Hypertens. 1992;10:385\u201391.","journal-title":"J Hypertens"},{"key":"86_CR3","first-page":"103","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","unstructured":"Centers for Disease Control and Prevention. Vital signs: prevalence, treatment, and control of hypertension\u2013United States, 1999\u20132002 and 2005\u20132008. MMWR Morb Mortal Wkly Rep. 2011;60:103\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"86_CR4","first-page":"1462","volume":"28","author":"G Mancia","year":"2007","unstructured":"Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2007;28:1462\u2013536.","journal-title":"Eur Heart J"},{"key":"86_CR5","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1097\/HJH.0b013e328333146d","volume":"27","author":"G Mancia","year":"2009","unstructured":"Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens. 2009;27:2121\u201358.","journal-title":"J Hypertens"},{"key":"86_CR6","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa022273","volume":"348","author":"DL Clement","year":"2003","unstructured":"Clement DL, De Buyzere ML, De Bacquer DA, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med. 2003;348:2407\u201315.","journal-title":"N Engl J Med"},{"key":"86_CR7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/01.HYP.0000170138.56903.7a","volume":"46","author":"E Dolan","year":"2005","unstructured":"Dolan E, Stanton A, Thijs L, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension. 2005;46:156\u201361.","journal-title":"Hypertension"},{"key":"86_CR8","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","volume":"359","author":"K Jamerson","year":"2008","unstructured":"Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359:2417\u201328.","journal-title":"N Engl J Med"},{"key":"86_CR9","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","volume":"366","author":"B Dahlof","year":"2005","unstructured":"Dahlof B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366:895\u2013906.","journal-title":"Lancet"},{"key":"86_CR10","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1751-7176.2010.00397.x","volume":"13","author":"AH Gradman","year":"2011","unstructured":"Gradman AH, Basile JN, Carter BL, et al. Combination therapy in hypertension. J Clin Hypertens (Greenwich). 2011;13:146\u201354.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"86_CR11","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/HJH.0b013e328322cd62","volume":"27","author":"E Dolan","year":"2009","unstructured":"Dolan E, Stanton AV, Thom S, et al. Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients\u2014an Anglo-Scandinavian cardiac outcomes trial substudy. J Hypertens. 2009;27:876\u201385.","journal-title":"J Hypertens"},{"key":"86_CR12","first-page":"499","volume":"20","author":"V Nagy","year":"2010","unstructured":"Nagy V, Lantos E, Habony N. A study investigating the antihypertensive effect of the fixed combination of perindopril\u2013amlodipine\u2014the PEARL study [in Hungarian]. Lege Artis Med. 2010;20:499\u2013507.","journal-title":"Lege Artis Med"},{"key":"86_CR13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF03256570","volume":"9","author":"VK Bahl","year":"2009","unstructured":"Bahl VK, Jadhav UM, Thacker HP. Management of hypertension with the fixed combination of perindopril and amlodipine in daily clinical practice: results from the STRONG prospective, observational, multicenter study. Am J Cardiovasc Drugs. 2009;9:135\u201342.","journal-title":"Am J Cardiovasc Drugs"},{"key":"86_CR14","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0140-6736(05)67186-3","volume":"366","author":"NR Poulter","year":"2005","unstructured":"Poulter NR, Wedel H, Dahlof B, et al. Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA). Lancet. 2005;366:907\u201313.","journal-title":"Lancet"},{"key":"86_CR15","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1524-6175.2006.05504.x","volume":"8","author":"MA Tedesco","year":"2006","unstructured":"Tedesco MA, Natale F, Calabro R. Effects of monotherapy and combination therapy on blood pressure control and target organ damage: a randomized prospective intervention study in a large population of hypertensive patients. J Clin Hypertens (Greenwich). 2006;8:634\u201341.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"86_CR16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1524-6175.2003.02674.x","volume":"5","author":"MA Weber","year":"2003","unstructured":"Weber MA. Creating a combination antihypertensive regimen: what does the research show? J Clin Hypertens (Greenwich). 2003;5:12\u201320.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"4","key":"86_CR17","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/01.hjh.0000163132.84890.c4","volume":"23","author":"E O\u2019Brien","year":"2005","unstructured":"O\u2019Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, et al. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens. 2005;23(4):697\u2013701.","journal-title":"J Hypertens"},{"key":"86_CR18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrcardio.2010.201","volume":"8","author":"S Oparil","year":"2011","unstructured":"Oparil S. Hypertension in 2010: new challenges in blood pressure goals and assessment. Nat Rev Cardiol. 2011;8:73\u20135.","journal-title":"Nat Rev Cardiol"},{"key":"86_CR19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/009286151104500303","volume":"45","author":"E O\u2019Brien","year":"2011","unstructured":"O\u2019Brien E. Why ABPM should be mandatory in all trials of blood pressure-lowering drugs. Drug Inf J. 2011;45:233\u20139.","journal-title":"Drug Inf J"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-013-0086-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-013-0086-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-013-0086-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T21:47:30Z","timestamp":1563054450000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-013-0086-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,17]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["86"],"URL":"https:\/\/doi.org\/10.1007\/s40261-013-0086-9","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,17]]}}}